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Abstract
Background: A neoplastic tumor cannot grow beyond a millimeter or so in diameter without
recruitment of endothelial cells and new blood vessels to supply nutrition and oxygen for tumor
cell survival. This study was designed to investigate formation of new blood vessels within a human
growing breast cancer tumor model (MDA MB231 in mammary fat pad of nude female mouse).
Once the tumor grew to 35 mm3, it developed a well-vascularized capsule. Histological sections of
tumors greater than 35 mm3 were stained with PAS, with CD-31 antibody (an endothelial cell
maker), or with hypoxia inducible factor 1α antibody (HIF). The extent of blood vessel and
endothelial cell pseudopod volume density was measured by ocular grid intercept counting in the
PAS stained slides.
Results: The tumor area within 100–150 µm of the well-vascularized capsule had few blood vessels
and only occasional endothelial cell pseudopods, whereas the area greater than 150 µm from the
capsule had more blood vessels, capillaries, and a three-fold increase in volume density of
pseudopods sprouting from the capillary endothelial cells. This subcortical region, rich in
pseudopods, some of which were observed to have vacuoles/lumens, was strongly positive for
presence of HIF. In some larger tumors, pseudopods were observed to insinuate for mm distances
through hypoxic regions of the tumor.
Conclusion: The positive correlation between presence of HIF and the increased extent of
pseudopods suggests volume density measure of the latter as a quantifiable marker of tumor
hypoxia. Apparently, hypoxic regions of the tumor produce HIF leading to production of vascular
endothelial growth factors that stimulate sprouting of capillary endothelial cells and formation of
endothelial cell pseudopods.

Background
Most tissues in the non-growing adult body have an ade-

quate vascular supply with no need for formation of new
blood vessels. Growth in tissue or tumor mass however
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requires recruitment of endothelial cells to form new
blood vessels. In an early report, new blood capillaries
were directly observed to form by sprouting of pseudopods from existing endothelial cells [1]. Speidel reported
endothelial cell sprouting in the regenerating tail fin of
the frog (Rana clamitans) 6 day after amputation. He saw
capillary sprouts that progressed for 32 µm through the
tissue over a 50-minute period, leaving a solid capillary
sprout behind. Up to seven side sprouts or pseudopods
also arose along the length of this main capillary sprout
during this 50-minute period. He also observed a sprout
that acquired a vacuole that fused with the capillary
lumen and allowed entry of an erythrocyte from the capillary lumen. This report of morphological events
involved in capillary cell sprouting and pseudopod formation remains the most definite description of endothelial cell sprouting and pseudopod formation.
The recruitment of endothelial cells by a tumor is a key
early step in tumor angiogenesis [2]. This tumor angiogenic process has become an important target in cancer
therapy [2-4]. There is now strong molecular and genetic
support for targeting tumor angiogenesis [2-4]. However,
there is much more to be learned about tumor angiogenesis. In our own investigation of angiogenesis of the
human breast cancer tumors (MDA MB231) growing in
the female nude mouse xenograft, we discovered that
staining 8 µm thick histological mid-cross sections of the
tumor with the periodic acid-Schiff (PAS) technique for
glycoproteins [5] revealed an unexpected abundance of
PAS positive endothelial cell pseudopods. The distribution of endothelial cell pseudopods was observed not to
be random throughout the tumor. This is the report of a
study done to determine the spatial pattern and the possible explanation for this non-random pattern of endothelial cell pseudopods during tumor angiogenesis.

Results
A total of 10 tumors greater than 35 mm3 were fixed,
embedded in paraffin wax and midsections were cut at 8
µm thickness for staining and histological study. Histological examination of midsections of PAS stained tumors
was done to assess the tumor vascularization patterns.
Tumors with a volume >35 mm3 demonstrated a connective tissue capsule with blood vessels (Fig. 1A). At higher
magnification the cortical area within about 100 µm of
the capsule revealed few blood vessels while the area
greater than 100 µm from the capsule showed considerable evidence of blood vessels and of capillaries with many
endothelial pseudopods extending away from the capillaries (Fig. 1B&C). The general direction of the pseudopods was parallel to the tumor capsule surface.
Immunohistochemical localization of CD-31, used as a
specific marker of blood vessel endothelium, demonstrated a positive reaction of pseudopods (Fig. 1D). Areas
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of tumor necrosis were observed below the subcortical
area (Fig. 1E&F). Immunohistochemical localization of
hypoxia inducible factor 1-α (HIF) reveals the subcortical
area of the tumor to contain HIF positive cells while the
tumor capsule, cortex and necrotic areas of the tumor
demonstrate no evidence of HIF. Thus, the areas found to
be HIF positive were enriched in endothelial pseudopods.
Ocular grid intercept counting was used to quantify tumor
vascularization in 8 µm thick PAS stained histological sections of the tumors. The numbers of ocular grid intercepts
were scored over: 1.) blood vessels and capillaries, 2.)
endothelial pseudopods and 3.) areas with no indication
of these structures. This method has been shown to be a
usable measure of volume density occupied by recognizable structures. The results of the scoring of blood vessels
and of endothelial pseudopods in the subcortical regions
of the tumors are summarized in Fig. 2. As illustrated in
Fig. 2, there was significantly less pseudopod volume density in the cortical versus the subcortical region of the
tumor.
Can the observation of PAS positive endothelial cell pseudopods be generalized to human breast cancer surgical
biopsy specimens? To address this question, specimens
from 15 breast cancer patients, obtained from the University of Texas Health Science Center at San Antonio Department of Pathology, were examined. Of these 15 patients,
nine were diagnosed with ductal confinement intraductal
carcinoma, or "DCIC." Although five showed multilayering of cancer cells within the ducts, none showed evidence
of endothelial pseudopods within this cancer cell population. Seven of the biopsy specimens were diagnosed as
invasive ductal carcinoma, or "IDS." Six of the seven IDS
specimens showed evidence of endothelial pseudopods
but to a lesser extent than in the MDA MB231 human
breast cancer tumor used in the current study. Two IDS
tumor specimens had visible regions of necrosis. The
region of the tumor adjacent to these necrosis regions had
more pseudopods than seen elsewhere in the tumor.
Thus, PAS positive endothelial cell pseudopods were commonly present in the human IDS specimens.

Discussion
The PAS stained histological sections of the tumors were
useful for identification of the spatial pattern of tumor
vascularization. Not only could blood vessels and capillaries be identified in the tumor but numerous pseudopods were also observed sprouting from capillaries. The
positive reaction to the CD-31 endothelial marker confirmed that the PAS stained structures were blood vessels,
capillaries and pseudopods of endothelial cell origin. Figure 3 is a drawing that summarizes the observed distribution of blood vessels and endothelial cell pseudopods.
Tumors greater then 35 mm3 revealed distinct areas of
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Figure 1
Photomicrographs
illustrating the pattern of the tumor vascularization
Photomicrographs illustrating the pattern of the tumor vascularization. A, The tumor capsule (left) of this PAS stained section
reveals blood vessels. The cortex under the capsule reveals no blood vessels and few endothelial pseudopods while the subcortical area to the top right has more pseudopods. B, at higher magnification the subcortical area of the tumor reveals a blood
capillary with multiple endothelial pseudopods protruding at right angles into the tumor mass. C, Endothelial pseudopods are
seen to branch and occasionally have a vacuole/lumen (arrow). D, The endothelial pseudopods react immunohistochemically
positive for the CD-31 specific endothelial cell marker, using the avidin-biotin peroxidase complex method. E, Viable cell area
can be seen beneath tumor capsule (left) while necrotic area can be seen to the right. F, Enlarged subcortical area from E. In E,
the HIF-α positive area between the viable and the necrotic tissue is stained brown.
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Quantification of volume density differences of endothelial
cell pseudopods in the tumor cortex, within 100 to 150 µm
of the well-vascularized tumor capsule, and in the subcortical
region at a distance of greater than 150 µm beneath the
tumor capsule. The mean ± SEM of the pseudopod volume
density of 10 tumors in the two different regions of the
tumors indicate a significant (p < 0.001) three fold higher
value of pseudopod volume density in the subcortical region
compared to the cortical region of the tumor.

viable and necrotic tissue. An area of viable tumor cells
was observed beneath the vascularized tumor capsule. The
area of viable tumor cells had two distinct subdivisions.
The cortical areas of the tumor within 100 to 150 microns
of the tumor capsule was not well vascularized and had
few endothelial pseudopods whereas the subcortical area
further than 100 to 150 microns from the tumor capsule
had blood vessels and had many more endothelial pseudopods. Even further beneath the tumor capsule, in the
areas of tumor necrosis, there was no evidence of blood
vessels, capillaries or endothelial pseudopods.
The observed localization of HIF in the tumors by immunohistochemistry helped explain the vascular pattern of
the encapsulated tumors. The HIF positive reactivity in the
tumor was localized in the subcortical areas of the tumor
in the same area found to have the most endothelial cell
pseudopods (Fig. 2). These findings suggest that this sub-
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Model of vascularization as observed in the human MDA
MB231 breast cancer cell tumor grown as a xenograph in a
female nude mouse. The well vascularized tumor capsule
overlies the tumor cortex. The cortex extends between 100
and 150 µm beneath the capsule. The HIF-α positive region
is located in the subcortical region, at distances greater than
150 µm of the capsule. More endothelial pseudopods are
located in this subcortical region than are located in the cortical region of the tumor. Even further away from the vascularized capsule is the region of tumor necrosis which
contains no blood vessels or endothelial cell pseudopods.
This model is consistent with the conclusion that the hypoxic
regions of the tumor produce HIF leading to production of
vascular endothelial growth factors and sprouting of
endothelial cell pseudopods.

cortical area of the tumor is hypoxic and is producing angiogenesis growth factors, which in turn acts on the host
endothelial cells to sprout pseudopods. Sprouting of cultured endothelial cells in response to vascular endothelial
growth factors has been reported [6]. In the same report,
Feraud et al. demonstrated that several angiostatic agents
could inhibit this endothelial cell sprouting. The presence
of pseudopodial like structures in viable areas of a tumor
immediately adjacent to necrotic areas of the tumor has
been previously reported [7]. The lack of HIF reactivity
beneath the well vascularized tumor capsule in the cortical area suggests this cortical area is not hypoxic and not
in need of an extensive vasculature. Apparently, the PAS
staining of endothelial cell pseudopods in tumors gives
quantifiable spatial information on where in the tumor
that HIF and vascular endothelial growth factors are
located.
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Materials and Methods
A detailed account of the materials and methods used in
this study has been published elsewhere [8]. Thus, only a
summary is given here. Fifteen 6-week-old female athymic
nude mice where fed AIN-76 semipurified diet altered to
contain 10% corn oil. Two millions human breast cancer
cells were inoculated into the inguinal mammary fat pad
of each mouse. Once the tumors had grown to greater
than 35 mm3 the mice were euthanized by injection of a
ketamine/rompun anesthesia supplied by the University
of Texas Health Science Center at San Antonio Laboratory
Animal veterinarian, then cervically dislocated and exsanguinated by cardiac puncture. The tumors were then
removed and fixed in Omni Fix II (Mt. Vernon, NY), dehydrated and embedded in paraffin, sectioned at 4 or 8 µm
thickness, mounted on slides, deparaffinized, and stained
with H&E or with periodic acid-Schiff (PAS). Additional
slides were stained for the immunohistochemical markers
for endothelial cells, CD-31 (PECAM-1, PharMingen) or
for hypoxia-inducible factor 1-alpha (#OSA-601, Stressgen). Quantification of the volume density of endothelial
cell pseudopods was done on the 8 µm thick PAS stained
histological sections of the tumors using counts of the
number of ocular grid line intercepts.
Archived surgical biopsy specimens that had been fixed in
10% neutralized formalin were dehydrated and embedded in paraffin. Histological sections of the specimens
were stained with H&E for routine histopathology examination or with PAS to assess endothelial cell pseudopod
distribution.
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